home / stock / pavm / pavm short
Short Information | PAVmed Inc. (NASDAQ:PAVM)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 204,961 |
Total Actual Volume | 1,405,432 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 10,248 |
Average Short Percentage | 16.23% |
Is there a PAVM Short Squeeze or Breakout about to happen?
See the PAVM Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $0.75 | $0.71 | $0.79 | $0.71 | 51,996 | 8,270 | 15.91% |
07-01-2024 | $0.815 | $0.764 | $1.09 | $0.764 | 129,147 | 26,748 | 20.71% |
06-28-2024 | $0.86 | $0.815 | $0.8675 | $0.761 | 22,772 | 2,618 | 11.5% |
06-27-2024 | $0.75 | $0.7667 | $0.848657 | $0.75 | 17,835 | 4,484 | 25.14% |
06-26-2024 | $0.778 | $0.742 | $0.778 | $0.741 | 35,249 | 7,520 | 21.33% |
06-25-2024 | $0.829 | $0.741 | $0.8499 | $0.5999 | 71,808 | 8,683 | 12.09% |
06-24-2024 | $0.83 | $0.7712 | $0.84 | $0.75 | 55,569 | 2,752 | 4.95% |
06-21-2024 | $0.871 | $0.8296 | $0.9 | $0.8221 | 67,663 | 3,154 | 4.66% |
06-20-2024 | $0.9253 | $0.8536 | $0.955 | $0.84 | 93,982 | 18,066 | 19.22% |
06-18-2024 | $1 | $0.925 | $1.01 | $0.920098 | 46,886 | 5,343 | 11.4% |
06-17-2024 | $1.06 | $1.01 | $1.06 | $0.9501 | 94,930 | 19,746 | 20.8% |
06-14-2024 | $1.08 | $1.06 | $1.09 | $1.05 | 32,119 | 2,667 | 8.3% |
06-13-2024 | $1.04 | $1.11 | $1.14 | $1.04 | 275,268 | 9,632 | 3.5% |
06-12-2024 | $1.16 | $1.05 | $1.25 | $1.05 | 74,142 | 19,190 | 25.88% |
06-11-2024 | $1.12 | $1.16 | $1.3 | $1.1 | 33,711 | 6,588 | 19.54% |
06-10-2024 | $1.19 | $1.15 | $1.25 | $1.145 | 33,622 | 6,985 | 20.78% |
06-07-2024 | $1.15 | $1.16 | $1.21 | $1.095 | 55,992 | 11,658 | 20.82% |
06-06-2024 | $1.2 | $1.13 | $1.2899 | $1.13 | 115,462 | 21,324 | 18.47% |
06-05-2024 | $1.3 | $1.18 | $1.3706 | $1.18 | 49,671 | 15,392 | 30.99% |
06-04-2024 | $1.39 | $1.29 | $1.47 | $1.29 | 47,608 | 4,141 | 8.7% |
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute PR Newswire First patients enrolled on the Veris Cancer Care Platform NEW YORK , ...
4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing PR Newswire Firefighter #CheckYourFoodTube Precancer Testing Event organized by Mass General Brigham physicians and Boston Firefighters Local 718 IAFF NEW YORK , June...